000 01490 a2200385 4500
005 20250513133710.0
264 0 _c19980225
008 199802s 0 0 eng d
022 _a0090-6980
024 7 _a10.1016/s0090-6980(97)00144-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPerkins, D J
245 0 0 _aTumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDs.
_h[electronic resource]
260 _bProstaglandins
_cOct 1997
300 _a727-43 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmnion
_xcytology
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xpharmacology
650 0 4 _aCells, Cultured
650 0 4 _aCyclooxygenase 1
650 0 4 _aCyclooxygenase 2
650 0 4 _aDexamethasone
_xpharmacology
650 0 4 _aDinoprostone
_xbiosynthesis
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aGlucocorticoids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aIsoenzymes
_xdrug effects
650 0 4 _aMembrane Proteins
650 0 4 _aProstaglandin-Endoperoxide Synthases
_xdrug effects
650 0 4 _aRNA, Messenger
_xbiosynthesis
650 0 4 _aTumor Necrosis Factor-alpha
_xpharmacology
700 1 _aKniss, D A
773 0 _tProstaglandins
_gvol. 54
_gno. 4
_gp. 727-43
856 4 0 _uhttps://doi.org/10.1016/s0090-6980(97)00144-5
_zAvailable from publisher's website
999 _c9409431
_d9409431